Medigen Biotechnology Corp. (TPEX:3176)
31.90
+0.05 (0.16%)
Apr 2, 2025, 1:30 PM CST
Medigen Biotechnology Revenue
In the year 2024, Medigen Biotechnology had annual revenue of 1.37B TWD with 18.57% growth. Medigen Biotechnology had revenue of 330.64M in the quarter ending December 31, 2024, a decrease of -10.88%.
Revenue
1.37B
Revenue Growth
+18.57%
P/S Ratio
3.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.37B | 214.98M | 18.57% |
Dec 31, 2023 | 1.16B | 101.77M | 9.64% |
Dec 31, 2022 | 1.06B | -2.87B | -73.08% |
Dec 31, 2021 | 3.92B | 3.31B | 537.17% |
Dec 31, 2020 | 615.54M | 63.20M | 11.44% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Pegavision | 6.82B |
Center Laboratories | 1.62B |